LIMN

Liminatus Pharma

0.2191

-0.0109-4.74%

After Hours: 0.2120 -0.0071 -3.24%19:57 04/17 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.2161/0.2300

TODAY RANGE0.2047-0.2400

VOL3.93M

MARKET CAP9.83M

52 WEEK RANGE0.1592-33.66

AVG VOL (3M)11.28M

% TURNOVER8.75%

TURNOVER--

P/E (TTM)-0.5099

% RANGE15.35%

EPS(TTM)-0.4297

P/E(FORWARD)--

P/B-0.6042

BVPS-0.3626

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.83M

SHARES OUTSTANDING44.88M

NEXT EARNINGS06/01-06/05

FREE FLOAT22.06M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·03/31 21:31
Liminatus Pharma FY25 net loss widens to $10.2 million; operating loss narrows to $3 million
TipRanks·03/17 12:16
Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody
Reuters·03/17 12:08
Liminatus Pharma plans Phase 1 trial of CD47 antibody IBA101 in lung cancer
Reuters·03/17 12:08
LIMINATUS PHARMA ANNOUNCES PLANNED PHASE 1 CLINICAL TRIAL OF IBA101, A NEXT-GENERATION CD47 BLOCKING ANTIBODY
TipRanks·03/04 22:25
Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment
Reuters·03/04 21:17
Liminatus Pharma Cuts Shareholder Meeting Quorum to One-Third
TipRanks·02/18 22:57
Liminatus Pharma Completes $4 Million Public Equity Offering
TipRanks·02/17 13:55
Liminatus Pharma prices 13.8M shares at 29c in public offering
Reuters·02/17 13:44
Liminatus Pharma Announces $4 Million Public Offering With Warrants
Reuters·02/17 13:44
LIMINATUS PHARMA INC - OFFERING PRICE SET AT $0.29 PER SHARE
Reuters·02/11 22:42
Iris Acquisition Corp. II Files Initial Statement of Beneficial Ownership; Manish C. Shah Listed as Director
TipRanks·02/11 11:16
Liminatus Pharma files to sell 6.9M shares of common stock, warrants
Reuters·02/10 21:46
Iris Acquisition Corp. II Announces Publication of Unqualified Independent Audit Report
TipRanks·02/09 20:27
Liminatus Pharma Settles Litigation Through Equity Issuance
Reuters·02/09 20:03
LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILING

Same Industry

Name/Symbol

Change%

Price

REGN

GRDX

BIONTECH

BNTX

+0.78%

102.92

UTHR

VRTX

Siga Technologie

SIGA

+2.59%

4.760

Moderna

MRNA

-1.76%

53.72

CRL

MEDP

Talphera Inc

TLPH

-0.79%

0.8026

ICLR

CBPO

IQV

MOLECULAR PARTNERS AG

MOLN

+0.60%

4.205

ARCT

GILD

PRAH

INCY

Aptevo Therapeutics Inc

APVO

-5.88%

5.28

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.